α-SMA(+) CAFs can enhance hepatocellular carcinoma (HCC) resistance to chemotherapy by stimulating the HGF-MET-FRA1-HEY1 cascade reaction [106]. The gene discussed is MET; the disease is hepatocellular carcinoma.